Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL. - Mascolo A; Di Napoli R; Balzano N; D'Alessio E; Izzo I; Rossi F; Paolisso G; Capuano A; Sportiello L (Frontiers in pharmacology, 2023)